{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:58:36Z","timestamp":1790816316618,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","award":["ANR-17-EURE-0013"],"award-info":[{"award-number":["ANR-17-EURE-0013"]}],"id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","award":["ANR-18-IDEX-0001"],"award-info":[{"award-number":["ANR-18-IDEX-0001"]}],"id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["WELBIO-CR-2022A-02"],"award-info":[{"award-number":["WELBIO-CR-2022A-02"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021716","name":"Universit\u00e9 de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010682","name":"H2020 Society","doi-asserted-by":"publisher","award":["115881"],"award-info":[{"award-number":["115881"]}],"id":[{"id":"10.13039\/100010682","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bbalip.2023.159333","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T11:48:23Z","timestamp":1684756103000},"page":"159333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hepatic deletion of serine palmitoyl transferase 2 impairs ceramide\/sphingomyelin balance, bile acids homeostasis and leads to liver damage in mice"],"prefix":"10.1016","volume":"1868","author":[{"given":"Justine","family":"Lallement","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ily\u00e8s","family":"Raho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Merlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Rainteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Croyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody","family":"Schiffano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim","family":"Kassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Doignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Soty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriane","family":"Lachkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Krempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Van Hul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice D.","family":"Cani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Foufelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Amouyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Le Stunff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Magnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Tordjmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Cruciani-Guglielmacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2023.159333_bb0005","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides \u2013 lipotoxic inducers of metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2023.159333_bb0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/er.2007-0023","article-title":"Glucolipotoxicity: fuel excess and beta-cell dysfunction","volume":"29","author":"Poitout","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbalip.2023.159333_bb0015","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3390\/jcm10040792","article-title":"Roles of ceramides in non-alcoholic fatty liver disease","volume":"10","author":"Hajduch","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbalip.2023.159333_bb0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1042\/BJ20070025","article-title":"Is the mammalian serine palmitoyltransferase a high-molecular-mass complex?","volume":"405","author":"Hornemann","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2023.159333_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/biom10111497","article-title":"Sphingomyelinases and liver diseases","volume":"10","author":"Insausti-Urkia","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbalip.2023.159333_bb0030","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","article-title":"The sphingolipid salvage pathway in ceramide metabolism and signaling","volume":"20","author":"Kitatani","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbalip.2023.159333_bb0035","doi-asserted-by":"crossref","first-page":"9922","DOI":"10.1074\/jbc.H118.003522","article-title":"The long and the short of ceramides","volume":"293","author":"Wattenberg","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159333_bb0040","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1074\/jbc.M109.077610","article-title":"A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy","volume":"285","author":"Pewzner-Jung","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159333_bb0045","doi-asserted-by":"crossref","first-page":"27855","DOI":"10.1074\/jbc.R111.254359","article-title":"Many ceramides","volume":"286","author":"Hannun","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159333_bb0050","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","article-title":"CerS2 haploinsufficiency inhibits \u03b2-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance","volume":"20","author":"Raichur","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2023.159333_bb0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.bbalip.2023.159333_bb0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2023.159333_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00665","article-title":"Inhibiting ceramide synthesis attenuates hepatic steatosis and fibrosis in rats with non-alcoholic fatty liver disease","volume":"10","author":"Jiang","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbalip.2023.159333_bb0070","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2023.159333_bb0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.24681","article-title":"Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes","volume":"55","author":"Studer","year":"2012","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.bbalip.2023.159333_bb0080","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbalip.2023.159333_bb0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2023.159333_bb0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbalip.2023.159333_bb0095","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1038\/ncomms10166","article-title":"Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction","volume":"6","author":"Jiang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbalip.2023.159333_bb0100","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2337\/db16-0663","article-title":"An Intestinal Farnesoid X Receptor\u2013Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice","volume":"66","author":"Xie","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2023.159333_bb0105","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142865","article-title":"Suppressing the intestinal farnesoid X receptor\/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis","volume":"131","author":"Wu","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2023.159333_bb0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/BJ20101386","article-title":"Ceramide synthase 4 and de novo production of ceramides with specific N-acyl chain lengths are involved in glucolipotoxicity-induced apoptosis of INS-1 \u03b2-cells","volume":"438","author":"V\u00e9ret","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2023.159333_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molmet.2017.10.013","article-title":"Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances \u03b2-cell function of obese Zucker rats","volume":"8","author":"Campana","year":"2018","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbalip.2023.159333_bb0120","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0003-2697(74)90210-3","article-title":"Direct enzymatic procedure for the determination of liver glycogen","volume":"58","author":"Roehrig","year":"1974","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbalip.2023.159333_bb0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI16567","article-title":"The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity","volume":"111","author":"Viollet","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2023.159333_bb0130","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/hep.28675","article-title":"The P2X4 purinergic receptor impacts liver regeneration after partial hepatectomy in mice through the regulation of biliary homeostasis","volume":"64","author":"Besnard","year":"2016","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.bbalip.2023.159333_bb0135","doi-asserted-by":"crossref","first-page":"E370","DOI":"10.1152\/ajpendo.00299.2003","article-title":"Induction of control genes in intestinal gluconeogenesis is sequential during fasting and maximal in diabetes","volume":"286","author":"Mithieux","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2023.159333_bb0140","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.metabol.2013.09.005","article-title":"Intestinal gluconeogenesis is crucial to maintain a physiological fasting glycemia in the absence of hepatic glucose production in mice","volume":"63","author":"Penhoat","year":"2014","journal-title":"Metabolism."},{"key":"10.1016\/j.bbalip.2023.159333_bb0145","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/hep.26463","article-title":"The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice","volume":"58","author":"P\u00e9an","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2023.159333_bb0150","article-title":"TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload","volume":"3","author":"Bidault-Jourdainne","year":"2021","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"10.1016\/j.bbalip.2023.159333_bb0155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.devcel.2010.01.011","article-title":"Organogenesis and development of the liver","volume":"18","author":"Si-Tayeb","year":"2010","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbalip.2023.159333_bb0160","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/hep.28845","article-title":"Liver Serine Palmitoyltransferase (SPT) activity deficiency in early life impairs adherens junctions and promotes tumorigenesis","volume":"64","author":"Li","year":"2016","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.bbalip.2023.159333_bb0165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/jhep.2001.22646","article-title":"Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases","volume":"33","author":"Zollner","year":"2001","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.bbalip.2023.159333_bb0170","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/archinte.1972.03650040100009","article-title":"The roles of bile acids during the process of normal fat and cholesterol absorption","volume":"130","author":"Holt","year":"1972","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbalip.2023.159333_bb0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/j.2040-4603.2014.tb00548.x","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbalip.2023.159333_bb0180","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.bbalip.2023.159333_bb0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2023.159333_bb0190","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1074\/jbc.M707386200","article-title":"Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate","volume":"283","author":"Laviad","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159333_bb0195","doi-asserted-by":"crossref","first-page":"34472","DOI":"10.1074\/jbc.273.51.34472","article-title":"Purification and characterization of a membrane bound neutral pH optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain","volume":"273","author":"Liu","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159333_bb0200","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1073\/pnas.97.11.5895","article-title":"Cloning and characterization of the mammalian brain-specific, Mg2+\u2212dependent neutral sphingomyelinase","volume":"97","author":"Hofmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2023.159333_bb0205","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1194\/jlr.RA119000346","article-title":"Dietary inulin decreases circulating ceramides by suppressing neutral sphingomyelinase expression and activity in mice","volume":"61","author":"Deng","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2023.159333_bb0210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbalip.2023.159333_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13248","article-title":"Neutral sphingomyelinase-2 and cardiometabolic diseases","volume":"22","author":"Sindhu","year":"2021","journal-title":"Obes. Rev. Off. J. Int. Assoc. Study Obes."},{"key":"10.1016\/j.bbalip.2023.159333_bb0220","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12017-010-8120-z","article-title":"Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses","volume":"12","author":"Wu","year":"2010","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.bbalip.2023.159333_bb0225","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbior.2014.10.002","article-title":"Roles and regulation of neutral Sphingomyelinase-2 in cellular and pathological processes","volume":"57","author":"Shamseddine","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.bbalip.2023.159333_bb0230","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0021-9258(18)52461-3","article-title":"Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation","volume":"266","author":"Kim","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159333_bb0235","doi-asserted-by":"crossref","first-page":"14617","DOI":"10.1074\/jbc.271.24.14617","article-title":"A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway","volume":"271","author":"Adam","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"169","key":"10.1016\/j.bbalip.2023.159333_bb0240","first-page":"5161","article-title":"Interaction with factor associated with neutral sphingomyelinase activation, a WD motif-containing protein, identifies receptor for activated C-kinase 1 as a novel component of the signaling pathways of the p55 TNF receptor","volume":"1950","author":"Tcherkasowa","year":"2002","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.bbalip.2023.159333_bb0245","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.2337\/db16-1232","article-title":"Adipocyte-specific deficiency of de novo sphingolipid biosynthesis leads to lipodystrophy and insulin resistance","volume":"66","author":"Lee","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2023.159333_bb0250","doi-asserted-by":"crossref","first-page":"10902","DOI":"10.1074\/jbc.M109.077594","article-title":"A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways","volume":"285","author":"Pewzner-Jung","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159333_bb0255","doi-asserted-by":"crossref","first-page":"13775","DOI":"10.1074\/jbc.M212262200","article-title":"Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism","volume":"278","author":"Marchesini","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159333_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.923769","article-title":"Lipidic profile changes in exosomes and microvesicles derived from plasma of monoclonal antibody-treated psoriatic patients","volume":"10","author":"Paolino","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbalip.2023.159333_bb0265","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2011.11.001","article-title":"Chain length-specific properties of ceramides","volume":"51","author":"Gr\u00f6sch","year":"2012","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbalip.2023.159333_bb0270","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/pro.3484","article-title":"Bile salt hydrolases: structure and function, substrate preference, and inhibitor development","volume":"27","author":"Dong","year":"2018","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"10.1016\/j.bbalip.2023.159333_bb0275","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tem.2017.11.002","article-title":"Role of bile acids in metabolic control","volume":"29","author":"Molinaro","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bbalip.2023.159333_bb0280","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0966-842X(00)88906-4","article-title":"Bacterial translocation from the gastrointestinal tract","volume":"3","author":"Berg","year":"1995","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bbalip.2023.159333_bb0285","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1053\/jhep.2003.50116","article-title":"Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats","volume":"37","author":"Lorenzo-Z\u00fa\u00f1iga","year":"2003","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.bbalip.2023.159333_bb0290","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1053\/j.gastro.2003.11.058","article-title":"Cholic acid supplementation enhances cholesterol absorption in humans","volume":"126","author":"Woollett","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbalip.2023.159333_bb0295","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1002\/hep4.2099","article-title":"Glycine-\u03b2-muricholic acid antagonizes the intestinal farnesoid X receptor-ceramide axis and ameliorates NASH in mice","volume":"6","author":"Jiang","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.bbalip.2023.159333_bb0300","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1210\/en.2004-0965","article-title":"Regulation of carbohydrate metabolism by the farnesoid X receptor","volume":"146","author":"Stayrook","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2023.159333_bb0305","doi-asserted-by":"crossref","first-page":"29971","DOI":"10.1074\/jbc.M501931200","article-title":"The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition","volume":"280","author":"Duran-Sandoval","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2023.159333_bb0310","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3892\/mmr.2014.2099","article-title":"\u03b2-catenin is overexpressed in hepatic fibrosis and blockage of Wnt\/\u03b2-catenin signaling inhibits hepatic stellate cell activation","volume":"9","author":"Ge","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbalip.2023.159333_bb0315","first-page":"C1055","article-title":"The role of the sphingolipid pathway in liver fibrosis: an emerging new potential target for novel therapies","volume":"318","author":"Ishay","year":"2020","journal-title":"Am. J. Phys. Cell Phys."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198123000574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198123000574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:14:37Z","timestamp":1761387277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198123000574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":63,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1388198123000574"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2023.159333","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic deletion of serine palmitoyl transferase 2 impairs ceramide\/sphingomyelin balance, bile acids homeostasis and leads to liver damage in mice","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2023.159333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"159333"}}